Skip to main content

Advertisement

SpringerLink
Log in

Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

This study evaluated whether a history of lifetime methamphetamine (MA) use disorder increases risk for poor sleep quality in people with or without HIV infection (HIV+/HIV−). Participants (n = 313) were stratified into four groups based on HIV status and lifetime MA use disorder diagnosis [HIV+/MA+ (n = 84); HIV+/MA− (n = 141); HIV−/MA+ (n = 16); and HIV−/MA− (n = 72)] and compared on global sleep outcomes using the Pittsburgh Sleep Quality Index (PSQI). Significant differences on global sleep were observed between HIV+/MA+ and HIV+/MA− groups, but not between the HIV− groups. Follow-up multiple regression analyses within the HIV+ subgroups examined global sleep scores as a function of MA status and clinical covariates, including those related to HIV disease and demographics. HIV+ individuals with a history of MA use disorder evidenced significantly poorer sleep quality and were more likely to be classified as problematic sleepers than those without a lifetime disorder. This was independent of depressed mood, body mass index, and viral suppression while on treatment. Poorer reported sleep quality among HIV+/MA+ was associated also with multiple adverse functional outcomes, including greater objective cognitive impairment, unemployment, clinical ratings of functional impairment, and self-reported cognitive difficulties, decreased independence in activities of daily living, and poorer overall life quality. Interventions to avoid or curtail MA use in HIV+ individuals may help protect sleep quality and improve functioning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Clark JP III, Sampair CS, Kofuji P, Nath A, Ding JM. HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R656–R662662.

    CAS  PubMed  Google Scholar 

  2. Wu J, Wu H, Lu C, Guo L, Li P. Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med. 2015;16(8):901–7.

    PubMed  Google Scholar 

  3. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111.

    PubMed  Google Scholar 

  4. Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197–209.

    PubMed  PubMed Central  Google Scholar 

  5. Semple SJ, Patterson TL, Temoshok LR, McCutchan JA, Straits-Troster KA, Chandler JL, et al. Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. Women Health. 1993;20(4):15–36.

    CAS  PubMed  Google Scholar 

  6. Rondanelli M, Solerte SB, Fioravanti M, Scevola D, Locatelli M, Minoli L, et al. Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Res Hum Retroviruses. 1997;13(14):1243–9.

    CAS  PubMed  Google Scholar 

  7. Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and risk factors of sleep disturbance in a large hiv-infected adult population. Aids Behav. 2016;20(2):339–44.

    CAS  PubMed  Google Scholar 

  8. Passaro RC, Pandhare J, Qian HZ, Dash C. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477–86.

    PubMed  PubMed Central  Google Scholar 

  9. Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala. Uganda Aids Patient Care St. 2005;19(11):760–8.

    Google Scholar 

  10. Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, et al. Speed kills: associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depen. 2019;195:164–9.

    Google Scholar 

  11. Wang X, Ho WZ. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci. 2011;88(21–22):972–9.

    CAS  PubMed  Google Scholar 

  12. Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, et al. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018;71:108–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820–6.

    PubMed  Google Scholar 

  14. Fairbairn N, Kerr T, Milloy MJ, Zhang R, Montaner J, Wood E. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav. 2011;36(7):762–3.

    PubMed  PubMed Central  Google Scholar 

  15. Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, et al. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013;7(4):255–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14.

    CAS  PubMed  Google Scholar 

  17. Chang L, Ernst T, Speck O, Grob CS. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162(2):361–9.

    PubMed  PubMed Central  Google Scholar 

  18. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat. 2002;22(3):149–56.

    PubMed  Google Scholar 

  19. Kish SJ. Pharmacologic mechanisms of crystal meth. CMAJ. 2008;178(13):1679–82.

    PubMed  PubMed Central  Google Scholar 

  20. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005;58(10):770–8.

    CAS  PubMed  Google Scholar 

  21. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61(1):73–84.

    PubMed  Google Scholar 

  22. Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, et al. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008;94(1–3):258–62.

    CAS  PubMed  Google Scholar 

  23. Mahoney JJ III, De La Garza R, Jackson BJ II, Verrico CD, Ho A, Iqbal T, et al. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014;219(2):367–71.

    PubMed  PubMed Central  Google Scholar 

  24. Tang J, Liao Y, He H, Deng Q, Zhang G, Qi C, et al. Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry. 2015;15:28.

    PubMed  PubMed Central  Google Scholar 

  25. Lago JA, Kosten TR. Stimulant withdrawal. Addiction. 1994;89(11):1477–81.

    CAS  PubMed  Google Scholar 

  26. Baberg HT, Nelesen RA, Dimsdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 1996;153(6):789–93.

    CAS  PubMed  Google Scholar 

  27. Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. Aids Care. 2003;15(6):775–85.

    CAS  PubMed  Google Scholar 

  28. World Health Organization. Composite diagnositic international interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.

    Google Scholar 

  29. Beck A, Steer R, Brown G. Manual for beck depression inventory II (BDI-II). San Antonio: Psychology Corporation; 1996.

    Google Scholar 

  30. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–21313.

    CAS  PubMed  Google Scholar 

  31. Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260–5.

    CAS  PubMed  Google Scholar 

  32. Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. J Clin Psychiatry. 2012;73(5):703–8.

    PubMed  PubMed Central  Google Scholar 

  33. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded halstead reitan battery: demographically adjusted neuropsychological norms for African American and caucasian adults. Lutz: Psychological Assessment Resources, Inc; 2004.

    Google Scholar 

  35. Heaton RK, Taylor MJ, Manly J. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. Clinical interpretation of the WAIS-III and WMS-III. San Diego: Academic Press; 2003. p. 181–210.

    Google Scholar 

  36. Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, et al. Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol. 2011;33(7):793–804.

    PubMed  PubMed Central  Google Scholar 

  37. Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26(6):894–908.

    CAS  PubMed  Google Scholar 

  38. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317–31.

    PubMed  Google Scholar 

  39. Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110–7.

    PubMed  PubMed Central  Google Scholar 

  40. Chelune GJ, Heaton RK, Lehman RAW. Neuropsychological and personality correlates of patients' complaints of disability. Advances in clinical neuropsychology, vol 3. New York: Plenum Press; 1986. p. 95–126.

    Google Scholar 

  41. Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139–M144144.

    CAS  PubMed  Google Scholar 

  42. Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007;5:54.

    PubMed  PubMed Central  Google Scholar 

  43. Dustin DT, Kawachi I, Redline S. The social epidemiology of sleep. New York: Oxford University Press; 2019.

    Google Scholar 

  44. Millar BM, Goedel WC, Duncan DT. Sleep health among sexual and gender minorities. Soc Epidemiol Sleep. 2019:187.

  45. Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2(4):194–9.

    PubMed  Google Scholar 

  46. Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56(1):8–17.

    CAS  PubMed  Google Scholar 

  47. Woods SP, Weber E, Weisz BM, Twamley EW, Grant I, Group HIVNRP. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011;56(1):77–84.

    PubMed  PubMed Central  Google Scholar 

  48. Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/aids undergoing art and factors associated with it. J Clin Diagn Res. 2014;8(10):1–4.

    Google Scholar 

  49. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry. 2004;12(6):305–20.

    PubMed  PubMed Central  Google Scholar 

  50. Jiao D, Liu Y, Li X, Liu J, Zhao M. The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci. 2015;9:162.

    PubMed  PubMed Central  Google Scholar 

  51. Padgett CL, Lalive AL, Tan KR, Terunuma M, Munoz MB, Pangalos MN, et al. Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron. 2012;73(5):978–89.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Kamata K, Kameyama T. Effect of chronic administration of methamphetamine on the responsiveness of substantia nigra zona reticulata neurons to GABA or a GABA agonist in rats. Naunyn Schmiedebergs Arch Pharmacol. 1986;334(4):458–62.

    CAS  PubMed  Google Scholar 

  53. Blumenfeld H. Neuroanatomy through clinical cases. 2nd ed. Sunderland: Sinauer Associates Inc.; 2012.

    Google Scholar 

  54. Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publication; 2013.

    Google Scholar 

  55. Downing MJ Jr, Houang ST, Scheinmann R, Yoon IS, Chiasson MA, Hirshfield S. Engagement in care, psychological distress, and resilience are associated with sleep quality among HIV-positive gay, bisexual, and other men who have sex with men. Sleep Health. 2016;2(4):322–9.

    PubMed  PubMed Central  Google Scholar 

  56. White JL, Darko DF, Brown SJ, Miller JC, Hayduk R, Kelly T, et al. Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. AIDS. 1995;9(9):1043–50.

    CAS  PubMed  Google Scholar 

  57. Norman SE, Chediak AD, Freeman C, Kiel M, Mendez A, Duncan R, et al. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep. 1992;15(2):150–5.

    CAS  PubMed  Google Scholar 

  58. Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990;4(8):775–81.

    CAS  PubMed  Google Scholar 

  59. Wiegand M, Moller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, et al. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci. 1991;240(3):153–8.

    CAS  PubMed  Google Scholar 

  60. Ferini-Strambi L, Oldani A, Tirloni G, Zucconi M, Castagna A, Lazzarin A, et al. Slow wave sleep and cyclic alternating pattern (CAP) in HIV-infected asymptomatic men. Sleep. 1995;18(6):446–50.

    CAS  PubMed  Google Scholar 

  61. Jean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, et al. Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. Sleep. 2012;35(1):131–7.

    PubMed  PubMed Central  Google Scholar 

  62. Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Sympt Manag. 2009;38(6):882–93.

    Google Scholar 

  63. Weissman MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245–50.

    CAS  PubMed  Google Scholar 

  64. Thomsen DK, Mehlsen MY, Christensen S, Zachariae R. Rumination—relationship with negative mood and sleep quality. Personality Individ Differ. 2003;34(7):1293–301.

    Google Scholar 

  65. Heitkemper M, Jarrett M, Burr R, Cain K, Landis C, Lentz M, et al. Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterol Motil. 2005;17(4):523–30.

    CAS  PubMed  Google Scholar 

  66. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53(3):737–40.

    PubMed  Google Scholar 

  67. Gutierrez J, Tedaldi EM, Armon C, Patel V, Hart R, Buchacz K. Sleep disturbances in HIV-infected patients associated with depression and high risk of obstructive sleep apnea. SAGE Open Med. 2019;7:2050312119842268.

    PubMed  PubMed Central  Google Scholar 

  68. Palmer CA, Alfano CA. Sleep and emotion regulation: an organizing, integrative review. Sleep Med Rev. 2017;31:6–16.

    PubMed  Google Scholar 

  69. Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep. 2013;36(7):1027–32.

    PubMed  PubMed Central  Google Scholar 

  70. O'Brien EM, Mindell JA. Sleep and risk-taking behavior in adolescents. Behav Sleep Med. 2005;3(3):113–33.

    PubMed  Google Scholar 

Download references

Acknowledgements

The San Diego HIV Neurobehavioral Research Center [HNRC] group is affiliated with the University of California, San Diego, the Naval Hospital, San Diego, and the Veterans Affairs San Diego Healthcare System, and includes: Director: Robert K. Heaton, Ph.D., Co-Director: Igor Grant, M.D.; Associate Directors: J. Hampton Atkinson, M.D., Ronald J. Ellis, M.D., Ph.D., and Scott Letendre, M.D.; Center Manager: Thomas D. Marcotte, Ph.D.; Jennifer Marquie-Beck, M.P.H.; Melanie Sherman; Neuromedical Component: Ronald J. Ellis, M.D., Ph.D. (P.I.), Scott Letendre, M.D., J. Allen McCutchan, M.D., Brookie Best, Pharm.D., Rachel Schrier, Ph.D., Debra Rosario, M.P.H.; Neurobehavioral Component: Robert K. Heaton, Ph.D. (P.I.), J. Hampton Atkinson, M.D., Steven Paul Woods, Psy.D., Thomas D. Marcotte, Ph.D., Mariana Cherner, Ph.D., David J. Moore, Ph.D., Matthew Dawson; Neuroimaging Component: Christine Fennema-Notestine, Ph.D. (P.I.), Monte S. Buchsbaum, M.D., John Hesselink, M.D., Sarah L. Archibald, M.A., Gregory Brown, Ph.D., Richard Buxton, Ph.D., Anders Dale, Ph.D., Thomas Liu, Ph.D.; Neurobiology Component: Eliezer Masliah, M.D. (P.I.), Cristian Achim, M.D., Ph.D.; Neurovirology Component: David M. Smith, M.D. (P.I.), Douglas Richman, M.D.; International Component: J. Allen McCutchan, M.D., (P.I.), Mariana Cherner, Ph.D.; Developmental Component: Cristian Achim, M.D., Ph.D.; (P.I.), Stuart Lipton, M.D., Ph.D.; Participant Accrual and Retention Unit: J. Hampton Atkinson, M.D. (P.I.), Jennifer Marquie-Beck, M.P.H.; Data Management and Information Systems Unit: Anthony C. Gamst, Ph.D. (P.I.), Clint Cushman; Statistics Unit: Ian Abramson, Ph.D. (P.I.), Florin Vaida, Ph.D. (Co-PI), Anya Umlauf, M.S., Bin Tang, Ph.D. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, nor the United States Government.

Funding

This research was supported by the National Institute on Drug Abuse: Grant Numbers P50 DA026306, T32 DA031098 (stipend support to NS), and F31 AG064989 (stipend support to RS).

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of California San Diego, San Diego, CA, USA

    Ni Sun-Suslow, Rowan Saloner, Vanessa Serrano, Anya Umlauf, Erin E. Morgan, Ronald J. Ellis, Scott Letendre, Igor Grant & Robert K. Heaton

  2. San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA

    Rowan Saloner

  3. Department of Neurosciences, University of California San Diego, San Diego, San Diego, CA, USA

    Ronald J. Ellis

  4. Department of Medicine, University of California San Diego, San Diego, CA, USA

    Scott Letendre

  5. Department of Psychiatry (0603), UCSD School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA

    Robert K. Heaton

Authors
  1. Ni Sun-Suslow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rowan Saloner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vanessa Serrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anya Umlauf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erin E. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ronald J. Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Scott Letendre
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Igor Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Robert K. Heaton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert K. Heaton.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (UCSD Human Research Protections Program, HNRC IRB#172092) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun-Suslow, N., Saloner, R., Serrano, V. et al. Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV. AIDS Behav 24, 3071–3082 (2020). https://doi.org/10.1007/s10461-020-02857-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-020-02857-7

Keywords

Search

Navigation